Spots Global Cancer Trial Database for Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer
Official Title: Randomized Phase II Study of Amrubicin as Single Agent or in Combination With Cisplatin Versus Etoposide-cisplatin as First-line Treatment in Patients With Extensive Stage SCLC (ES)
Study ID: NCT00388960
Conditions
Study Description
Brief Summary: The purpose of the study is to document the activity and safety of single agent amrubicin, amrubicin combined with cisplatin, and etoposide combined with cisplatin as first-line treatment in extensive disease small cell lung cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Algemeen Ziekenhuis Middelheim, Antwerpen, , Belgium
Universitair Ziekenhuis Antwerpen, Edegem, , Belgium
Universiteit Gent, Gent, , Belgium
U.Z. Gasthuisberg, Leuven, , Belgium
Domaine Universitaire du Sart-Tilman, Liege, , Belgium
Centre Hospitalier Regional de la Citadelle, Liege, , Belgium
Clinique Sainte Elisabeth, Namur, , Belgium
Instituto Nazionale per la Ricerca sul Cancro, Genova, , Italy
Universita Degli Studi Di Udine, Udine, , Italy
Academisch Medisch Centrum, Amsterdam, , Netherlands
The Netherlands Cancer Institute Antoni Van Leeuwenhoekziekenhuis, Amsterdam, , Netherlands
Medisch Spectrum Twente - Dept of Pulmonary Diseases, Enschede, , Netherlands
Leiden University Medical Centre, Leiden, , Netherlands
Academisch Ziekenhuis Maastricht, Maastricht, , Netherlands
Isala Kliniek, Zwolle, , Netherlands
Medical University of Gdansk - Dept Radiotherapy, Gdansk, , Poland
Clatterbridge Centre for Oncology NHS Trust, Bebington, Merseyside, United Kingdom
University of Dundee - Ninewells Hospital, Dundee, Scotland, United Kingdom
Belfast City Hospital, Belfast, , United Kingdom
Western General Hospital, Edinburgh, , United Kingdom
Princess Royal Hospital, Hull, , United Kingdom
Royal Marsden Hospital, London, London, , United Kingdom
Christie Hospital, Manchester, , United Kingdom
Sir Bobby Robson Cancer Trials Research Centre, Newcastle-Upon-Tyne, , United Kingdom
Royal Marsden Hospital Lung Unit, Sutton, , United Kingdom
Contact Details
Name: Mary O'Brien, MD
Affiliation: Royal Marsden Hospital, London, UK
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
